Invesaro

Stocks IBIO Earnings

Earnings

iBio, Inc. (IBIO) earnings

Quarterly results of iBio, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when IBIO files with the SEC.

Next earnings date

iBio, Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q4 FY2026

In Q4 FY2026 (ended June 30, 2026) iBio, Inc. reported revenue of - and a net loss of $10.6M.

Filed with the SEC on August 28, 2026.

Revenue by quarter
Q1 25: $0 $0 Q1 25Q2 25: $200K $200K Q2 25Q3 25: $0 $0 Q3 25Q4 25: $200K $200K Q4 25Q1 26: $100K $100K Q1 26Q2 26: $0 $0 Q2 26
Net income by quarter
Q1 25: -$4M -$4M Q1 25Q2 25: -$4.4M -$4.4M Q2 25Q3 25: -$4.9M -$4.9M Q3 25Q4 25: -$5.2M -$5.2M Q4 25Q1 26: -$5.7M -$5.7M Q1 26Q2 26: -$9M -$9M Q2 26Q3 26: -$7.7M -$7.7M Q3 26Q4 26: -$10.6M -$10.6M Q4 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q4 FY2026June 30, 2026---$10.6M-
Q3 FY2026March 31, 2026---$7.7M-$0.06
Q2 FY2026December 31, 2025$0--$9M-$0.09
Q1 FY2026September 30, 2025$100K--$5.7M-$0.11
Q4 FY2025June 30, 2025$200K--$5.2M-
Q3 FY2025March 31, 2025$0--$4.9M-$0.49
Q2 FY2025December 31, 2024$200K--$4.4M-$0.48
Q1 FY2025September 30, 2024$0--$4M-$0.46

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is iBio, Inc.'s next earnings date?

iBio, Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Get an email when IBIO reports

Follow IBIO and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when IBIO files with the SEC.

Source: quarterly figures iBio, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about iBio, Inc.